GATC Biotech conducts research to detect cancer in women
GATC Biotech has started research on early detection of breast and ovarian cancer with the goal of developing a test to identify tumor markers present in blood and link these markers to the presence of cancer.
As a partner of the research project EpiFemCare, GATC Biotech will manage sample processing, i.e. the DNA isolation from serum and the reduced representation bisulfite sequencing from serum derived DNA. This method analyses DNA methylation in normal and tumor DNA. 6 institutions from 5 European countries combining the best clinical, scientific and industrial expertise have joined forces to add a new dimension to the treatment of cancer in women. The € 5.8 Mio project from the European Commission will develop and test new methods for screening, diagnosing and personalising treatment of breast and ovarian cancer.
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Who trusts gene-edited foods? - New study gauges public acceptance
Dow Corning Ramps Up Pharmaceutical Grade Silicone Tubing Production in Response to Influenza Outbreak
Marinomed Granted Chinese Patent for Antiviral Polymer
Heptares provides Gpcr expertise to new European drug discovery consortium - Consortium supported with over €20 million funding from EU Innovative Medicines Initiative and big pharma
ERYtech Pharma and Genzyme Corporation Sign Collaborative Research Agreement in Rare Diseases
New cancer gene discovered
Aquapharm appoints new Chief Scientific Officer

Hypoallergenic pets: dream or reality? - Luxembourg Institute of Health navigates the science behind supposed ‘sneeze-free’ animals

Cellular protein shredders for the fight against cancer - How a cellular mechanism can be used for other purposes
Research and Markets: Company and Industry Analysis of the US $ 14.9 Billion Asia-Pacific Biotechnology Market
Research and Markets: Riding the Biotech Economic Tsunami - Surfing to Safety or Wipeout?
